ClassID:

94945

C07D303/48 - CPC Classification

Classification description:

Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom; Compounds containing oxirane rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. ester or nitrile radicals

Recent Application in this class:
#1
20260098007
2026-04-09

Compounds and Their Use in Filtering Ultraviolet and/or High-Energy Visible Light

#2
20240391887
2024-11-28

New VASHs inhibitors, conjugates thereof and their uses as drugs or as research tools

#3
20230271929
2023-08-31

METHOD FOR PRODUCING COMPOUND

#4
20230122812
2023-04-20

Compound producing method, and compound

#5
20220363626
2022-11-17

TREPROSTINIL DERIVATIVES AND COMPOSITIONS AND USES THEREOF

#6
20210139441
2021-05-13

USES OF FLUORINATED EPOXIDES AND NOVEL MIXTURES THEREOF

#7
20210009501
2021-01-14

Treprostinil derivatives and compositions and uses thereof

#8
20200339562
2020-10-29

COVALENT BTK INHIBITORS AND USES THEREOF

#9
20200095186
2020-03-26

Treprostinil derivatives and compositions and uses thereof

#10
20200010439
2020-01-09

PROCESSES FOR PREPARING PARTIALLY FLUORINATED EPOXIDES AND PERFLUORINATED EPOXIDES AND COMPOSITIONS RELATED THERETO

#11
20190305374
2019-10-03

Electrolyte for rechargeable lithium battery and rechargeable lithium battery

#12
20190062290
2019-02-28

2,3-epoxy succinyl derivative, preparation method and use thereof

#13
20190031586
2019-01-31

Organic compound, three-dimensional organic framework formed by using organic compound, separation sieve and optical layer, which comprise organic framework, and optical device comprising optical layer as optical amplification layer

#14
20190015387
2019-01-17

Selective androgen receptor degrader (SARD) ligands and methods of use thereof

#15
20190010112
2019-01-10

Treprostinil derivatives and compositions and uses thereof

#16
20180016222
2018-01-18

Treprostinil derivatives and compositions and uses thereof

#17
20170369783
2017-12-28

Polymerizable compound and optically anisotropic object

#18
20170306233
2017-10-26

Polymerizable compound and optically anisotropic body

#19
20170253570
2017-09-07

AMIDE-LINKED PERFLUOROPOLYETHER THIOL COMPOUNDS AND PROCESSES FOR THEIR PREPARATION AND USE

#20
20170008884
2017-01-12

Cysteine protease inhibitors and uses thereof

#21
20160368854
2016-12-22

Treprostinil derivatives and compositions and uses thereof

#22
20160115160
2016-04-28

2,3-butanediamide epoxide compound and preparation method and use thereof

#23
20160102067
2016-04-14

OXIRAN AMINES

#24
20160068701
2016-03-10

Dialkyl 2, 5-furandicarboxylate plasticizers and plasticized polymeric compositions

#25
20150313229
2015-11-05

Substituted [1,2,4] Triazole Compounds

#26
20150291492
2015-10-15

Cross coupling of 2-bromo-1-phenyl indenes with phenyl acetylenes and other substituted acetylenes in water

#27
20150183754
2015-07-02

FATTY ACID INHIBITORS

#28
20150174089
2015-06-25

Substituted aminobutyric derivatives as neprilysin inhibitors

#29
20150119573
2015-04-30

Method for synthesizing sapropterin dihydrochloride

#30
20150105551
2015-04-16

Oxidative degradation products of atrovastatin calcium

#31
20150051362
2015-02-19

Amide-linked perfluoropolyether thiol compounds and processes for their preparation and use

#32
20150045393
2015-02-12

Cysteine protease inhibitors and uses thereof

#33
20140243537
2014-08-28

Process for the preparation of oseltamivir and methyl 3-epi-shikimate

#34
20140128255
2014-05-08

Fungicidal alkyl-substituted 2[2-chloro-4-(4-chioro-phenoxy)-phenyl]-1[1,2,4]triazol-1-yl-ethanol compounds

#35
20130317190
2013-11-28

COPOLYMERIZABLE SURFACTANTS

#36
20130131359
2013-05-23

PROCESSES AND INTERMEDIATES FOR PREPARING STERIC COMPOUNDS

#37
20130018094
2013-01-17

Prophylactic or Therapeutic Agent For Gum Disease or Apical Periodontitis

#38
20130006001
2013-01-03

Manufacture of an epoxyethyl carboxylate or glycidyl carboxylate

#39
20120322761
2012-12-20

Heterocyclic CETP inhibitors

#40
20120252830
2012-10-04

Substituted aminobutyric derivatives as neprilysin inhibitors

#41
20120197015
2012-08-02

EPOXYCARBOXAMIDE COMPOUND, AZIDE COMPOUND, AND AMINO ALCOHOL COMPOUND, AND PROCESS FOR PREPARING a-KETO AMIDE COMPOUND USING THEM

#42
20120016142
2012-01-19

Method for producing hexafluoropropylene oxide

#43
20120010281
2012-01-12

ANTIMICROBIAL AND ANTITUBERCULAR COMPOUNDS

#44
20110275838
2011-11-10

METHOD FOR OBTAINING CINATRINS C3 AND C1

#45
20110245262
2011-10-06

Compounds for treating proliferative disorders

#46
20110237765
2011-09-29

Amide-linked perfluoropolyether thiol compounds and processes for their preparation and use

#47
20110226733
2011-09-22

Patterning process

#48
20110190389
2011-08-04

OXYLIPINS FROM LONG CHAIN POLYUNSATURATED FATTY ACIDS AND METHODS OF MAKING AND USING THE SAME

#49
20110105458
2011-05-05

Fatty acid inhibitors

#50
20110071074
2011-03-24

Deuterated hepatitis C protease inhibitors

#51
20110003993
2011-01-06

Salt of (2S, 3S)-3-[[(1S)-1-isobutoxymethyl-3-methylbutyl]carbamoyl]oxirane-2-carboxylic acid

#52
20100331545
2010-12-30

REGULATOR FOR SIGNALING TOLL-LIKE RECEPTOR, WHICH COMPRISES CATHEPSIN INHIBITOR AS ACTIVE INGREDIENT

#53
20100305145
2010-12-02

Substituted aminobutyric derivatives as neprilysin inhibitors

#54
20100298568
2010-11-25

Processes and intermediates for preparing steric compounds

#55
20100267669
2010-10-21

Heterocyclic CETP inhibitors

#56
20100219063
2010-09-02

OXIDATIVE DEGENERATION PRODUCTS OF ATORVASTATIN CALCIUM

#57
20100190848
2010-07-29

Cysteine-protease inhibitors

#58
20100144917
2010-06-10

ACTINIC ENERGY RADIATION HARDENABLE COMPOSITION AND EPOXY COMPOUND

#59
20100056605
2010-03-04

OXIDATIVE DEGRADATION PRODUCTS OF ATORVASTATIN CALCIUM

#60
20100048909
2010-02-25

Process for production of optically active-3-amino-2-hydroxypropionic cyclopropylamide derivatives and salts thereof

#61
20100016615
2010-01-21

PROCESS FOR PRODUCTION OF HEXAFLUOROPROPYLENE OXIDE

#62
20100010242
2010-01-14

Process for preparing β-amino-α-hydroxycarboxamides

#63
20090312563
2009-12-17

Salt of (2S, 3S)-3-[[(1S)-1-isobutoxymethyl-3-methylbutyl] carbamoyl] oxirane-2-carboxylic acid

#64
20090170009
2009-07-02

HOLOGRAPHIC RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM

#65
20090143467
2009-06-04

Anticancer agents based on regulation of protein prenylation

#66
20090124776
2009-05-14

Cycloaliphatic epoxy (meth)acrylates, preparation processes thereof, and copolymers

#67
20090124690
2009-05-14

Generation of Combinatorial Synthetic Libraries and Screening for Novel Proadhesins and Nonadhesins

#68
20080312404
2008-12-18

Novel diepoxides and epoxy resins

#69
20080249102
2008-10-09

HIV protease inhibitors

#70
20080176841
2008-07-24

Epoxide inhibitors of cysteine proteases

#71
20080064873
2008-03-13

Epoxycarboxamide compound, azide compound, and amino alcohol compound, and process for preparing α-keto amide compound using them

#72
20080058516
2008-03-06

Epoxycarboxamide compound, azide compound, and amino alcohol compound, and process for preparing alpha-keto amide compound using them

#73
20080015368
2008-01-17

Process for preparing β-amino-α-hydroxycarboxamides

#74
20070244334
2007-10-18

Processes and intermediates for preparing steric compounds

#75
20070225297
2007-09-27

Deuterated hepatitis C protease inhibitors

#76
20070208185
2007-09-06

Intermediates for the hemisynthesis of taxanes and preparation processes therefor

#77
20070208071
2007-09-06

Oxidative degradation products of atorvastatin calcium

#78
20070161622
2007-07-12

Diamino alcohols and their use as renin inhibitor

#79
20070135631
2007-06-14

Heterocyclic CETP inhibitors

#80
20060252826
2006-11-09

Salt of (2S, 3S) -3- [[(1S) -1- isobutoxymethyl-3-methylbutyl] carbamoly] oxirane-2-carboxylic acid

#81
20060234999
2006-10-19

Cephalotaxane derivatives and their processes of preparation and purification

#82
20060172952
2006-08-03

Aza-peptide epoxides

#83
20060154325
2006-07-13

Synthesis of epoxide based inhibitors of cysteine proteases

#84
20060128978
2006-06-15

Diepoxide derivatives of N,N*-disubstituted disulfonamides

#85
20060111329
2006-05-25

Anticancer agents based on regulation of protein prenylation

#86
20060094887
2006-05-04

Transition metal complex having diphosphine compound as ligand

#87
20050222089
2005-10-06

Intermediates for the hemisynthesis of taxanes and preparation processes therefor

#88
20050181455
2005-08-18

Generation of combinatorial synthetic libraries and screening for novel proadhesins and nonadhesins

#89
20050118248
2005-06-02

Amphiphilic derivatives for the production of vesicles, micelles and complexants, and precursors thereof

#90
20050090484
2005-04-28

Cephalotaxane derivatives and their processes of preparation and purification

#91
20050027131
2005-02-03

Polyamino acid-catalyzed process for the enantioselective epoxidation of α,β-unsaturated enones and α,β-unsaturated sulfones